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Abstract
Proopiomelanocortin-derived peptides exert pleiotropic effects via binding to melanocortin receptors (MCR). MCR-subtypes
have been detected in cartilage and bone and mediate an increasing number of effects in diathrodial joints. This study aims
to determine the role of MC1-receptors (MC1) in joint physiology and pathogenesis of osteoarthritis (OA) using MC1-
signaling deficient mice (Mc1re/e). OA was surgically induced in Mc1re/e and wild-type (WT) mice by transection of the
medial meniscotibial ligament. Histomorphometry of Safranin O stained articular cartilage was performed with non-
operated controls (11 weeks and 6 months) and 4/8 weeks past surgery. mCT–analysis for assessing epiphyseal bone
architecture was performed as a longitudinal study at 4/8 weeks after OA-induction. Collagen II, ICAM-1 and MC1 expression
was analysed by immunohistochemistry. Mc1re/e mice display less Safranin O and collagen II stained articular cartilage area
compared to WT prior to OA-induction without signs of spontaneous cartilage surface erosion. This MC1-signaling
deficiency related cartilage phenotype persisted in 6 month animals. At 4/8 weeks after OA-induction cartilage erosions
were increased in Mc1re/e knees paralleled by weaker collagen II staining. Prior to OA-induction, Mc1re/e mice do not differ
from WT with respect to bone parameters. During OA, Mc1re/e mice developed more osteophytes and had higher
epiphyseal bone density and mass. Trabecular thickness was increased while concomitantly trabecular separation was
decreased in Mc1re/e mice. Numbers of ICAM-positive chondrocytes were equal in non-operated 11 weeks Mc1re/e and WT
whereas number of positive chondrocytes decreased during OA-progression. Unchallenged Mc1re/e mice display smaller
articular cartilage covered area without OA-related surface erosions indicating that MC1-signaling is critical for proper
cartilage matrix integrity and formation. When challenged with OA, Mc1re/e mice develop a more severe OA-pathology. Our
data suggest that MC1-signaling protects against cartilage degradation and subchondral bone sclerosis in OA indicating a
beneficial role of the POMC system in joint pathophysiology.
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Introduction
Osteoarthritis is an age-related and/or trauma-induced multi-
factorial, slowly progressing degenerative disorder of the synovial
joints culminating in the irreversible destruction of the articular
cartilage. Clinical symptoms of OA appear in more than 10% of
the world population affecting almost everyone over the age of 65.
As a consequence of the increasing longevity and obesity in the
European Community, the burden caused by OA rapidly grows
substantially influencing life quality of the affected individuals with
enormous costs to the health care system. Current therapeutic
strategies seek to ameliorate pain and increase mobility, however,
to date none of them halts disease progression or regenerates
damaged cartilage. Thus, there is an ultimate need for the
development of non-invasive treatments that could substitute joint
replacement. OA exact aetiology is still unclear. Genetic disorders,
limb mal-alignment and overuse as well as metabolic problems
(obesity, immune responses, inflammation) play an important role
in the onset of OA. [1–4]. Besides chondrocytes and cartilage as
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mediators of OA also other cells and tissues of the joint like
synovium or subchondral bone modulate OA-pathogenesis.
Subchondral bone and articular cartilage are separated through
the tide mark region and have a close relationship during
progression of OA. Abnormal calcification of this tide mark
region during OA leads to a decrease in cartilage thickness and
increased subchondral plate thickness [5] preceded by increased
turnover of subchondral bone, thinning trabecular structures,
sclerosis of the subchondral plate, bone marrow lesions and
subchondral bone cysts [6,7]. Alterations in subchondral bone
remodeling add to biomechanical changes and enhance OA
progression [8,9].
Proopiomelanocortin (POMC) is a multifunctional precursor
protein for several biologically active hormones which include the
melanocyte-stimulating hormones (a-, b- and c-MSH) and
adrenocorticotropic hormone (ACTH). These peptides play an
important role in a diversity of physiological processes including
energy homeostasis, adrenal function, sexual activity, thermoreg-
ulation, nociception, exocrine gland activity, immune function,
and pigmentation. Although originally characterized as neurohor-
mones induced by stressful signals in context of the classical
hypothalamic-pituitary-adrenal (HPA) stress axis, it is now
established that POMC and its derived peptides can also be
autonomously generated in a number of peripheral tissues, e. g.
the skin and diathrodial joints. Here, receptors for POMC
peptides, the melanocortin receptors (MCR) have been identified
in various resident cell types where they elicit biological effects far
beyond the initially identified action of their ligands. A very
fascinating aspect of POMC-derived peptides is their immuno-
modulatory potential, especially that of melanocortin-derived
peptides [10–12].
The melanocortin peptides ACTH as well as a-, b- and c-MSH
bind with high affinity to melanocortin receptors [13]. Five MCR
subtypes, MC1 to MC5, have been cloned and which bind
melanocortins with different affinities. With respect to diathrodial
joints, initially the MC3 was detected in rat bone marrow stroma-
like cells and in chondrocytes isolated from ribcages of young rats
[14]. Our group recently demonstrated the presence of MC1,
MC2 and MC5 transcripts in human articular chondrocytes
derived from patients with OA [15]. Protein expression of the
MC1 in these cells was confirmed on OA cartilage explants. Here,
chondrocytes located in the middle and deep cartilage layers were
immuno-reactive for MC1 while chondrocytes in the superficial
zone were mostly negative. Treatment of these chondrocytes with
a-MSH was associated with functional coupling as shown by
cAMP assays but not with a Ca2+ response. The detection of MC1
in human articular chondrocytes is in accordance with the
observation that also a human chondrosarcoma cell line, likewise
expresses functional MC1 [16]. In addition, transcripts of all five
MCR were found in normal human osteoblasts as well as in MG63
and SAOS-2 osteosarcoma cells, albeit not all receptors were
present in each cell type [17].
For analyzing the role of the MC1 in pathogenesis of OA, we
have induced OA surgically in mice using the model of
destabilization of the medial meniscus (DMM) as it induces OA
with great ease and reproducibility. It is less invasive than the
anterior cruciate ligament transaction (ACLT) procedure and
resembles more closely slowly progressive human OA. It has been
shown to be sufficiently sensitive to detect significant protection
against OA progression in ADAMTS-5 and IL-1b knockout joints
at 4–8 weeks following DMM [18,19]. We assume that the DMM-
OA model will thus be sensitive enough to allow evaluation of the
hypothesized chondroprotective role of endogenously expressed
Mc1r in murine articular cartilage.
As a tool for analysis of the melanocortin system in OA, we have
used yellow colored MC1 signaling-deficient (Mc1re/e) mice. The
Mc1re/e- recessive yellow allele (e) results from a frameshift
between the IV. and V. transmembrane domain that produces a
prematurely terminated, non-functioning MC1 which does not
functionally couple to adenylate cyclase [20] but is still expressed
and transported to the cell membrane.
Materials and Methods
Mouse model
To evaluate the role of MC1 signaling during osteoarthritis
pathogenesis, Mc1re/e mice on a C57BL/6 background were
used [20]. C57BL/6 mice (Charles River) served as wild type (WT)
control group.
Study design
Right knees of Mc1re/e mice and WT received DMM while left
knee served as sham control with just the surgical access set.
Cartilage matrix was evaluated after histological assessment with
scoring [21] and histomorphometry whereas changes in subchon-
dral bone were evaluated with X-ray scoring and mCT. The
experimental protocol was approved by the local animal
experimental ethics committee (Az.: 54-2532.1-36/11) and all
procedures were performed according to the European Labora-
tory Animal Science Guidelines.
For histological assessment, 22 male WT and 21 male Mc1re/e
mice were included in study. 11 weeks (5 WT, 4 Mc1re/e) and 6
months (5 WT, 5 Mc1re/e) old, male mice received no DMM and
represent non-operated control group whereas 12 WT and 12
Mc1re/e received DMM (6 WT and 6 Mc1re/e mice for 4 and 8
weeks each). To analyze OA progression, Safranin O/Fast green
stained knee joint sections were scored and evaluated morpho-
metrically.
For X-ray scoring and mCT analysis, 7 WT (2 female, 5 male)
and 7 Mc1re/e (2 female, 5 male) mice received DMM. Changes
in epiphyseal bone micro-architecture and osteophyte number
were assessed directly before surgery (day 0) and 4 and 8 weeks
after OA-induction.
Surgically induced osteoarthritis
10–11 week old mice were anaesthetized by intraperitoneal
injection of ketamine-hydrochloride (90–120 mg/kg body weight,
Bela-pharma, Vechta) and Xylazin (6–8 mg/kg body weight,
Serumwerk Bernburg). DMM was performed as described
previously [19] from Dr. med. vet. Gerit Hackmayer (doctor of
veterinary medicine). In both knees, a 3 mm longitudinal incision
between the distal patella and proximal tibia plateau was set and
the joint capsule was opened medial to the patellar tendon. In the
right knee, the medial meniscotibial ligament (MMTL) was
carefully transected, while in left knee MMTL was visualized
but not transected (sham surgery). Joint capsule, subcutaneous
layer and skin were closed and mice were allowed full activity.
Mice were administered subcutaneous sodium chloride infusion
(10 ml/kg body weight) and Buprenorphin (0.09 mg/kg body
weight, Bayer vital) 12 and 24 h after operation in a longitudinal
study.
Histological preparation, OA-scoring and
histomorphometry
For histological preparation and morphometry, we correspond
mainly to the recommendation of OARSI [21]. Knee joints were
fixed for 18–24 h in 4% paraformaldehyde and decalcified with
25% EDTA for 2 weeks at room temperature and embedded in
MC1-Signaling and OA
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paraffin. 5 mm frontal sections through the weight bearing area of
each knee joint were taken. 5–6 sections in 60–80 mm intervals
from 6 mice per time point were stained with Safranin O, Weigerts
iron haematoxylin and fast green and scored by two independent
observers.
Additionally, histomorphometry was performed with the same
sections used for OA-scoring using graphic tablet Bamboo
(Wacom) and image J software (NIH, Bethesda). On sections of
knee joints from non-operated mice, total cartilage area was
determined in pixel. On sections of knee joints from non-operated
mice, 4 and 8 weeks after OA-induction, total articular cartilage
area and cartilage area without cells/Safranin O staining
(destroyed cartilage) was determined in pixel. Destroyed cartilage
area was related to total cartilage area which was set as 100%.
For both methods medial regions of the knee joints were
analyzed and mean values of femur and tibia scores were included
in statistical analysis.
Localization of MC1, collagen II, matrix metalloproteinase
13 (MMP-13), aggrecan neoepitope DIPEN(341)/
(342)FFGVG (DIPEN) and intracellular adhesion molecule
1(ICAM-1)
For each antigen, 1–3 representative sections in the weight
bearing area of 4–6 different mice per time point were chosen and
included in staining. For immunostaining of MC1, collagen II,
MMP-13, DIPEN and ICAM-1, following antibodies were used:
rabbit anti-mouse mc1r [22], mouse anti-mouse collagen II
(DSHB), rabbit-anti MMP-13 (Abcam), rabbit anti-DIPEN (a
generous gift from Amanda Fosang (University of Melbourne)) and
rabbit-anti-ICAM (BioVision).
Sections were deparaffinized, rehydrated and endogenous
peroxidase activity was blocked with 3% H2O2 for 5 min at RT.
For MC1, collagen II, MMP-13 and DIPEN staining, sections
were pre-incubated with protease XXIV (0.05% in PBS for
10 min at 37uC, Sigma-Aldrich) and with testicular hyaluronidase
(0.1% in acetate buffer pH 6.0 for 90 min at 37uC, Sigma-
Aldrich). For staining of specimen with antibodies against ICAM,
heat induced epitope retrieval was performed for 20 min at 98 uC
in 10 mM sodium citrate buffer, pH 6.0. This was followed by a
cooling period at room temperature for 20 min.
Sections were incubated over night at 4uC with MC1, MMP-13,
DIPEN or ICAM-1 antibodies (1:75 dilution in blocking solution
for MC1-ab, 1:600 for MMP-13-ab, 1:5000 for DIPEN-ab and
1:100 for ICAM-1-ab), after blocking with 1% bovine serum
albumin (Biomol) and 5% swine serum (Dako). 1 h incubation
with a biotinylated swine anti-rabbit (1:500 diluted in PBS, Dako)
was followed by an incubation with streptavidin-peroxidase and
buffered substrate solution containing H202 and 3,3-diaminoben-
zidine chromogen solution (Dako). The secondary antibody for the
ICAM-1-staining was provided with the Envision kit (Dako)
according to manufacturer’s instruction (incubation time was
30 min). Sections were counterstained with hematoxylin modified
after Gil (Merck), dehydrated and mounted.
For staining of sections with antibodies against collagen II, a
commercial biotinylation kit was used according to manufactor’s
instructions (Dako) with a 1:125 dilution of primary antibody.
Sections were counterstained with Weigert’s hematoxylin, dehy-
drated and mounted.
For MC1, collagen II, MMP-13, DIPEN and ICAM-1 staining,
images from both groups of each condition were compared and
evaluated microscopically. To quantify collagen II, MMP-13,
DIPEN and ICAM-1 stained sections, a scoring system was
applied. For collagen II stained sections, percentage of stained
cartilage area (see Tab. 1), for MMP-13 staining, percentage of
positive non-hypertrophic articular chondrocytes (see Tab. 2) and
for ICAM-1 and DIPEN, percentage of stained articular
chondrocytes was estimated (see Tab. 3). To evaluate scoring
systems for collagen II, MMP-13, DIPEN and ICAM-1 staining,
intra- and inter-observer agreement was determined with cohens
kappa coefficients. Therefore 7 independent observers scored 10
frontal sections of each staining and 4 of them scored the same
images after 1 week again. To score the images, observers got no
further information except for scoring tables (Tab. 1–3) and 4
exemplary images with scores according to [21] (Fig. S4).
Sections incubated with appropriate isotype control antibody
served as negative control and showed no staining (Fig. S1).
X-ray Scoring
Mice were scanned under anesthesia by intraperitoneal
injection of ketamine hydrochloride (Ketavet: 120 mg/kg body
weight, Pfizer, Berlin, Germany) und medetomidine hydrochloride
(Domitor: 0.5 mg/kg body weight, Orion Pharma, Hamburg,
Germany) in the Sky-Scan 1076 in vivo x-ray microtomograph
(Skyscan, Antwerpen). Anesthesia was antagonized after mCT-scan
by subcutaneous administration of atipamezole hydrochloride
(Antisedan: 2.5 mg/kg body weight, Orion Pharma, Hamburg,
Germany). 2 Mc1re/e mice died due to anesthesia reducing the
group size to 5 mice (1 female, 4 male). Legs were hold in a
stretched position by a small styrofoam cylinder taped between
hind legs. Following settings were used for mCT analysis: 1 mm
aluminium filter, voxel size 8.85 mm, voltage 40 kV, current
250 mA, exposure time 2550 ms, frame averaging 2 [23]. Data
were recorded every 1.5 degree rotation step through 180 degrees.
Both legs were scanned in the same scan session and a shutter was
set to reduce X-ray exposure time (,20 min).
Micro-CT analysis
Reconstruction of X-ray scans was performed using NRecon
software (version 1.6.3.2, Skyscan). Datasets were separated using
DataViewer (Skyscan). Knees were manually analyzed for
osteophytes based on the reconstructed images in transaxial,
sagittal and coronal plane. Osteophytes were defined as abnormal
bony projections along the bony margin of the knee joints
appearing after 4 and 8 weeks of OA progression. Presence of
osteophytes was assessed by two independent investigators. For
further 3D analysis, tibia plateau was oriented along the growth
plate and tibial diaphysis according to transaxial, sagittal and
cortical plane. A volume of interest (VOI) of 40064006100 slices
per knee was set. Bone parameters were analyzed with CTAn
analysis software (Skyscan) with a threshold set at 55 to define
mineralized callous tissue. An interpolated VOI was set along the
outer bone boundaries of the tibia plateau excluding the growth
plate. For evaluating bone density the mean grayscale within the
VOI was determined. Changes in bone nature were calculated
regarding following 3D parameters: bone volume/tissue volume
(BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th)
and trabecular separation (Tb.Sp). Parameters are shown follow-
ing ASBMR nomenclature [24].
Statistical analysis
For statistical evaluation of histological and morphometric
scoring non-parametric Mann-Whitney-U test was used. A two-
tailed significance value of p,0.05 was considered statistically
significant. Data analysis was performed with GraphPad Prism 5
(San Diego).
After consultation of a statistician, the intra- and inter-observer
agreement of histological scoring systems was calculated using
MC1-Signaling and OA
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Cohens kappa coefficient. Hereby, a kappa value of 0 corresponds
to no agreement and a kappa value of 1.0 to complete agreement.
Kappa values between 0–0.20 indicate slight agreement, 0.21–
0.40 indicate fair agreement, 0.41–0.60 indicate moderate
agreement, 0.61–0.80 indicate substantial agreement and 0.81–
1.00 indicate excellent agreement. [25]. Data analysis was
performed with SPSS for Windows 22.0 (SPSS Inc., Chicago).
For mCT analysis all parameters were referred to the respective
value at day 0. For statistical comparison of Mc1re/e mice (n = 5)
with WT mice (n = 7), Mann-Whitney-U Signed-Rank tests was
conducted. For comparison of time points (day 0, 4 weeks and 8
weeks) Friedman-overall-test with post-hoc Wilcoxon-tests was
conducted. Only if Friedman-overall-test indicated significance,
data were analyzed post-hoc. Comparison of the right and the left
knee was done by a paired Wilcoxon-test. A two-tailed significance
value of p,0.05 was considered statistically significant. Data
analysis was performed with SPSS for Windows 16.0 (SPSS Inc.,
Chicago).
Results
Morphometric analysis of knee joint articular cartilage
from non-operated Mc1re/e and WT mice
Fig. 1A depicts representative Safranin O/fast green stained
image from a frontal section through a mouse knee joint. For OA
– induction always the meniscotibial ligament of the medial
meniscus (MM) was transected. For further evaluation always the
medial femoral condyle (MFC) and the medial tibial plateau
(MTP) were used. Articular cartilage morphology was assessed by
morphometric evaluation of Safranin O stained area of knee joints
of non-operated 11 weeks (Fig. 1B, C) and 6 months old animals
(Fig. 1D, E). In both age groups, cartilage area was smaller in
Mc1re/e mice compared to WT which was statistically significant.
Notably, we were unable to detect any signs of spontaneous OA-
related cartilage surface erosions.
Analysis of cartilage degradation during OA-
pathogenesis
Scoring and histomorphometric analysis of Safranin O stained
articular cartilage revealed that OA was successfully induced in
right knee joints of both Mc1re/e and WT mice (Fig. 2A). Both
evaluation methods indicated significant increase in severity of
cartilage degradation during OA progression in both groups. OA
scoring of non-operated Mc1re/e and WT mice reveal that there
is no spontaneous osteoarthritis induction in 11 weeks old (non-op;
Fig. 2B–E) and 6 months old (data not shown) animals.
Osteoarthritic related cartilage alterations as increasing loss of
ECM macromolecules and cartilage surface erosions were more
severe in Mc1re/e knee joints 4 and 8 weeks after OA induction
(p.o.) for both evaluation methods (Fig. 2B, C) while sham-
operated knees were unaffected (Fig. 2D, E).
Distribution of MC1 in DMM- and non-operated knee
joints of Mc1re/e and WT mice
Immunoreactivity for MC1 was tested on sections of knee joints
from non-operated 11 week old and 6 month old Mc1re/e and
WT animals and from mice 4 and 8 weeks after OA-induction
with DMM. Representative images are shown in Figure 3.
Immunostaining demonstrates the presence of MC1 in knee
joints of mice. Chondrocytes in menisci and the upper and the
adjunct part of the middle zone of articular cartilage are
immunopositive for MC1. In addition, chondrocytes of the growth
plate stain positive for MC1, here mainly cells in the proliferating
zone which are organized into columns are stained (Fig. S2).
Mostly, hypertrophic chondrocytes and also subpopulations of
bone cells in the subchondral bone area remain negative. There is
no difference in staining intensity or profile between WT and
Mc1re/e mice detectable after OA-induction. Also, in 11 weeks
and 6 months old non-operated mice MC1 distribution appears
not to be altered between mutant and WT group and during aging
(Fig. 3).
Collagen II, MMP-13, ICAM-1 and DIPEN in DMM- and
non-operated knee joints of WT and Mc1re/e mice
Immunoreactivity for collagen II, MMP-13, ICAM-1 and
DIPEN was tested on sections of knee joints from non-operated
11 week old and 6 month old Mc1re/e and WT animals and from
mice 4 and 8 weeks after OA-induction with DMM. Represen-
tative images of MC1, collagen II, MMP-13 and ICAM-1 were
shown in figure 3. Additionally a 0–4 point scoring system was
applied for all groups and antigens (Tab. 1, 2 and 3) and data are
presented for collagen II (Fig. 4A,), MMP-13 (Fig. 4B) and ICAM-
1 (Fig. 4C) staining. Images of DIPEN staining and quantitative
scoring is shown in Fig. S3. Immunohistology with appropriate
isotype control antibodies served as negative control and remained
unstained (Fig. S1).
In sections of 6 month old non-operated WT animals and of
WT mice 4 and 8 weeks after OA-induction, collagen II stained
articular cartilage is significantly decreased compared to non-
operated 11 week old control. In contrast, articular cartilage of
Mc1re/e showed no loss of collagen II staining in sections of 6
month old non-operated WT animals and of WT mice 4 and 8
weeks after OA-induction compared to non-operated 11 week old
controls. Between non-operated 11 weeks old Mc1re/e and WT
mice, collagen II stained knee joints revealed differences in stained
cartilage area with significantly less collagen II staining in Mc1re/e
joints. Also, 4 weeks after OA-induction there are significantly
more cartilage regions without collagen II staining in Mc1re/e
mice compared to WT. At 8 weeks after DMM this is reflected by
Table 1. Scoring system for collagen type II
immunohistochemistry.
Grade collagen type II staining in articular cartilage
0 articular cartilage is not stained
1 ,25% of articular cartilage area is stained
2 25–50% of articular cartilage area is stained
3 50–75% of articular cartilage area is stained
4 .75% of articular cartilage area is stained
doi:10.1371/journal.pone.0105858.t001
Table 2. Scoring system for MMP-13 immunohistochemistry.
Grade
MMP-13 stained non-hypertrophic chondrocytes in
articular cartilage
0 no chondrocytes are stained
1 ,25% of chondrocytes are stained
2 25–50% of chondrocytes are stained
3 50–75% of chondrocytes are stained
4 .75% of chondrocytes are stained
doi:10.1371/journal.pone.0105858.t002
MC1-Signaling and OA
PLOS ONE | www.plosone.org 4 September 2014 | Volume 9 | Issue 9 | e105858
trend only. At 6 month of age, collagen II staining pattern did not
differ between WT and Mc1re/e mice (Fig. 3 and Fig. 4A).
Cohens kappa coefficients showed a substantial (MFC: 0.64) and
moderate (MTP: 0.55) intra-observer agreement and a moderate
(MFC: 0.40, MTP: 0.46) inter-observer agreement (Fig. S4).
Immunoreactivity for MMP-13 was significantly increased in
MMP-13 positive non-hypertrophic articular chondrocytes 8
weeks after OA-induction and in sections of non-operated 6
months old animals compared to non-operated 11 weeks old mice.
In contrast, articular chondrocytes of Mc1re/e did not show an
increase of MMP-13 positive cells during OA-progression or
ageing compared to 11 weeks old non-operated mice. We
observed a significant higher number of MMP-13 positive non-
hypertrophic chondrocytes in Mc1re/e mice compared to WT in
Table 3. Scoring system for ICAM-1 and DIPEN
immunohistochemistry.
Grade ICAM-1/DIPEN stained chondrocytes in articular cartilage
0 no chondrocytes are stained
1 ,25% of chondrocytes are stained
2 25–50% of chondrocytes are stained
3 50–75% of chondrocytes are stained
4 .75% of chondrocytes are stained
doi:10.1371/journal.pone.0105858.t003
Figure 1. Histomorphometric comparison of knee joint morphology between non-operated Mc1re/e and WT mice. A) Overview of
Safranin O/Fast green stained frontal section of a right mouse knee joint from a non-operated 11 week old Mc1re/e mouse (406magnification).
Lateral femoral condyle (LFC), lateral tibial plateau (LTP) and lateral meniscus (LM) as well as medial femoral condyle (MFC), medial tibial plateau
(MTP) and medial meniscus (MM) are labeled. For osteoarthritis induction with DMM, the medial meniscotibial ligament is transected. B–E)
Histological evaluation of cartilage area was performed with Safranin O/Fast green stained frontal sections of right knee joints from non-operated 11
weeks old and 6 months old WT and Mc1re/e mice. B+D) Medial, tibial (dotted line) and femoral (broken line) Safranin O stained cartilage was
circuited with Bamboo tablet. C+E) Cartilage area of Mc1re/e mice was significantly smaller in 11 weeks (p = 0.0159) and 6 months old (p = 0.0079)
animals compared to cartilage area of WT mice. For statistical analyses mean values of tibial and femoral cartilage areas of 5–6 section per knee joint
was determined. Data are presented as boxplots reflecting the 25th and 75th percentile as boxes, the median as horizontal line and minimum and
maximum values as whiskers. Bars = 500 mm, * p,0.05 and ** p,0.01 wild type vs. Mc1re/e.
doi:10.1371/journal.pone.0105858.g001
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non-operated 11 weeks old animals. This difference persisted 4
weeks after OA-inductions and was not observed 8 weeks after
OA-induction and in non-operated 6 month old animals (Fig. 3
and Fig 4B). Cohens kappa coefficients showed a fair (MFC: 0.25)
and moderate (MTP: 0.50) intra-observer agreement and a
moderate (MFC: 0.40, MTP: 0.46) inter-observer agreement
(Fig. S4).
Notably, staining for ICAM-1 revealed strong signals in
chondrocytes of the articular cartilage and in chondrocytes mainly
of the hypertrophic zone of the growth plate (Fig. S2). In WT and
Mc1re/e animals, 6 month old non-operated animals and mice 4
and 8 weeks after OA-induction contain fewer ICAM-1 positive
articular chondrocytes compared to non-operated 11 week old
control. We detected no differences in ICAM-1 staining between
Mc1re/e and WT mice in non-operated 11 weeks old and 6
month old animals. 4 and 8 weeks after OA-induction, Mc1re/e
mice showed significantly less ICAM-1 positive articular chon-
drocytes in the medial part of the joints compared to WT (Fig. 3
and Fig. 4C). Cohens kappa coefficients showed a substantial
(MFC/MTP: 0.74) intra-observer agreement and a fair (MFC:
0.37, MTP: 0.32) inter-observer agreement (Fig. S4).
Staining for MMP-generated aggrecan neoepitope DIPEN
revealed highest immunoreactivity in articular cartilage
chondrocytes of 11 weeks old WT and Mc1re/e mice. 4 weeks
after OA-induction, number of DIPEN positive chondrocytes was
lower compared to 11 weeks old mice of both groups. Numbers of
DIPEN positive chondrocytes did not differ between WT and
Mc1re/e in age-matched mice and 4 and 8 weeks after OA-
induction (Fig. S3). Cohens kappa coefficients showed a substantial
(MFC: 0.61, MTP: 0.71) intra-observer agreement and a fair
(MFC: 0.26, MTP: 0.36) inter-observer agreement (Fig. S4).
Analysis of bone architecture at the day of surgery
(day 0)
Bone morphology of the epiphysis of the right tibia was
recorded at the day of surgery (day 0) by mCT analysis within a
VOI excluding the growth plate (Fig. 5A). The mean grayscale
was calculated as an indicator for bone density (Fig. 5). Bone
volume (BV) was calculated relative to total volume (TV) to
normalize on knee size and was used as an indicator for bone mass
(Fig. 5C). Bone density and BV/TV were similar between WT
and Mc1re/e mice at the day of surgery indicating no differences
in epiphyseal bone density and mass prior to OA induction.
Trabecular number (Tb.N, Fig. 5D) and trabecular thickness
(Tb.Th, Fig. 5E) did not differ between the groups at day 0
Figure 2. Assessment of cartilage degradation 4 and 8 weeks after osteoarthritis induction. A-E) Frontal sections of knee joints from WT
and Mc1re/e mice of non-operated (non-op) 11 week old animals, and of animals 4 and 8 weeks post operation (p.o.) by DMM were stained with
Safranin O/Fast green. A) Representative images of the medial area from sections of right knee joints from non-operated 11 weeks old animals and
from mice 4 and 8 weeks after osteoarthritis induction (p.o.) show disease progression over the time. B–E) 5–6 sections in 60–80 mm intervals of right
knees (DMM, B, C) and left knees (Sham, D, E) were scored histological according to Glasson et al. [21] (B, D) and morphometrically (C, E). B) We
observed OA-progression over time in WT (p = 0.0043) and Mc1re/e (p = 0.0095) mice compared to non-operated controls. Mc1re/e mice had higher
scores 4 weeks (p = 0.0411) and 8 weeks (p = 0.0649) after OA-induction. C) Percentages of degraded cartilage area also indicated an OA-progression
over time in WT (p = 0.0043) and Mc1re/e (p = 0.0095) compared to non-operated controls. Mc1re/e mice had more degraded cartilage 4 weeks
(p = 0.0649) and 8 weeks (p = 0.0411) after OA-induction compared to WT animals. D+E) Sham operated knee joints showed similar scores (D) and
area of degraded cartilage (E) compared to non-operated controls. Mean scores of medial tibia and femur were included in statistical analysis. Data
are presented as box plots reflecting the 25th and 75th percentile as boxes, the median as horizontal line and minimum and maximum values as
whiskers. White bars indicate wild type and grey bars indicate mutant group. Bars = 500 mm, 11 p,0.01 4/8 weeks post-surgery vs. non-operated,
* p,0.05 wild type vs. Mc1re/e.
doi:10.1371/journal.pone.0105858.g002
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whereas mutants showed an increased trabecular separation
(Tb.Sp, Fig. 5F).
Development of osteophytes in the joints of Mc1re/e
mice after OA-induction
Osteophytes were evident 4 weeks after OA-induction in 2 of 7
animals of the WT- and in 4 of 5 animals of the Mc1re/e group
(Fig. 6A–C). Only the right knee (DMM) was affected, sham-
operated knees did not develop osteophytes. Osteophytes were
increased in size at 8 weeks, but no additional novel osteophytes
became apparent 8 weeks after OA-induction (Fig. 6D).
Increased bone density and bone volume in knees of
Mc1re/e mice after OA-induction
DMM-knees developed areas of increased mineral deposition
during OA progression according to reconstructed images
(Fig. 7A, B). At 4 weeks the mean grayscale as an indicator for
bone density was significantly increased in the Mc1re/e group
compared to day 0. Eight weeks after OA-induction WT animals
revealed a significantly elevated bone density. At both time points,
Mc1re/e mice had higher bone density in the epiphysis (Fig. 7C).
BV/TV as an indicator of bone mass increased in the knee joints
of the Mc1re/e group only compared to day 0 and was higher
compared to the WT group 4 weeks and 8 weeks after OA-
induction (Fig. 7D).
Alterations in bone architecture are significant more
pronounced in Mc1re/e mice affecting also the
contra-lateral knee joints
In destabilized DMM knee joints, trabecular number (Tb.N)
declined significantly in WT and Mc1re/e at 4 and 8 weeks
compared to day 0 with no differences observed between both
groups (Fig. 8A).
Trabecular thickness (Tb.Th) was significantly increased in
DMM-knees of the Mc1re/e group at 4 and 8 weeks compared to
day 0. In the WT group an increase in Tb.Th was evident only at
8 weeks with trabeculae being significantly thinner compared to
the Mc1re/e group at both time points (Fig. 8B).
In line with an increase of Tb.Th was a decrease in Tb.Sp in
DMM knee joints of the Mc1re/e group reaching significance at 8
weeks compared to day 0. This decrease was not observed in the
WT group at these time points. At both time points, Mc1re/e
animals showed less Tb.Sp versus the WT group (Fig. 8C).
Interestingly, mild alterations in trabecular structure also
occurred in sham operated contra-lateral knees in both groups
within the set time span (Fig. 8D–E) but to a significantly lesser
extend compared to destabilized knees. However, no significant
changes in BV/TV were detected in contra-lateral knees of
animals of both groups (data not shown).
Discussion
Hallmark features of OA are structural changes including
cartilage destruction as well as alterations in synovial membrane
and subchondral bone. Synovial tissue and subchondral bone are
considered to play decisive roles in OA-pathology, but up to now
cartilage is the main target for therapeutic approaches because of
its paramount importance in joint articulation. However, current
therapies are palliative and there are no disease-modifying drugs
available for effective clinical use. One major reason for the lack of
curative therapies is that OA is mostly diagnosed in late or end
stage of the disease where joint replacement by endoprotheses
remains the only treatment option [26]. Thus, it is of great
importance to understand basic mechanisms of OA-pathology in
an early stage of the disease in order to develop effective
regenerative therapies. For that approach we have chosen surgical
OA induction with DMM in mice which allows to detect alteration
in cartilage and subchondral bone already early after induction of
OA and resembles quite closely slowly progressive human OA
[19].
There is compelling evidence that the osteoarticular system is a
direct target organ and source of POMC peptides [12]. Our study
provides novel evidence for a role of the POMC system in the
osteoarticular system and in OA-pathology. Mice which lack a
functional MC1 develop a cartilage phenotype which is reflected
in a smaller cartilage area, lower immunoreactivity for collagen II
and a higher number of MMP-13 positive chondrocytes. After
OA-induction, they develop more severe cartilage erosions and
tissue loss compared to WT. Of note, immunoreactivity for
ICAM-1 decreases during OA progression which is significantly
more pronounced in articular chondrocytes of Mc1re/e mice as in
WT. This effect supports our observation that MC1 signaling
helps to stabilize cartilage matrix integrity. Immunostaining for
MC1 revealed no difference between WT and MC1re/e mice.
Reduced collagen II and increased MMP-13 immunostaining in
non-operated Mc1re/e knees indicates a cartilage phenotype in
the mutant mice independent of OA pathology suggesting a
premature appearance of age – related structural ECM alterations
in the absence of a functional MC1.
Figure 3. Localization of MC1, collagen II, MMP-13 and ICAM-1
in knee joints of Mc1re/e and wild type mice. A+C) Frontal
sections of right knee joints from WT and Mc1re/e mice of non-
operated (non-op) 11 weeks old and 6 months old animals, and of mice
4 and 8 weeks after osteoarthritis induction (post operation (p.o.)) were
stained with antibodies against MC1, collagen II, MMP-13 and ICAM-1 as
described in material and methods. Representative pictures of medial
parts of the knee joints from each time point are shown. Bars = 200 mm.
doi:10.1371/journal.pone.0105858.g003
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With respect to epiphyseal bone architecture, we did not detect
obvious differences between Mc1re/e and WT mice regarding
bone density and mass at the day of DMM surgery. However,
trabecular separation was increased in Mc1re/e mice indicating a
slight, but distinct effect on bone marrow thickness. We cannot
exclude compensatory effects of other MCR subtypes in bone
tissue, i.e. MC2 and MC4, for which at least mRNA transcripts
are found in osteoblasts [17,27]. In addition to matrix producing
osteoblasts, bone contains also matrix degrading cells, the
osteoclasts which express MC2, MC3, MC4 and MC5 transcripts
[17]. Presumably, it needs challenging by inflicting traumata in
order to reveal physiological relevance of an individual MCR
subtype. With respect to cartilage morphology, histomorphometry
demonstrates that the area in knee joints covered by articular
cartilage surface was smaller in non-operated Mc1re/e mice
compared to WT. This observation indicates, together with less
collagen II stained area and a higher number of MMP-13 positive
chondrocytes in sections of knee joints of 11 weeks old mutant
mice, an OA – independent cartilage phenotype, however without
signs of OA typical surface erosions. Notably, immunoreactivity
for cellular MMP-generated aggrecan neoepitope DIPEN does not
differ between WT and Mc1re/e in articular chondrocytes at any
time point. Besides DIPEN, various other aggrecan neoepitopes
generated by MMPs and aggrecanases are known which indicate
aggrecan degradation. Our data suggest that presumably MMP-13
might not be the major proteinase causative for reduction of area
of safranin O stained cartilage in Mc1re/e mice. Again, there
might be some compensation as mRNA transcripts of other MCR
Figure 4. Quantitative scoring of collagen II, MMP-13 and ICAM-1 immunohistochemistry. Medial parts of frontal sections of right knee
joints from WT and Mc1re/e mice of non-operated (non-op) 11 weeks old and 6 months old animals, and of mice 4 and 8 weeks after osteoarthritis
induction (post operation (p.o.)) were scored after staining. 1-3 sections of right knees (DMM) were scored histological according to the scoring
system illustrated in Tab. 1 for collagen II, in Tab. 2 for MMP-13 and in Tab. 3 for ICAM-1 staining. A) Compared to non-operated controls collagen II
stained cartilage area of WT knee joints is decreased 4 weeks (p = 0.0079) and 8 weeks (p = 0.0043) after OA-induction as well as in non-operated 6
month old animals (p = 0.0159). Sections of Mc1re/e knee joints showed no difference over time. Collagen II stained cartilage area of non-operated 11
weeks old Mc1re/e mice (p = 0.0159) and Mc1re/e mice 4 weeks (p = 0.0159) after OA induction is decreased compared to WT mice. B) Compared to
non-operated controls number of MMP-13 positive non-hypertrophic articular chondrocytes of WT knee joints is increased 8 weeks (p = 0.0022) after
OA-induction as well as in non-operated 6 month old animals (p = 0.0076). Sections of Mc1re/e knee joints showed no difference over time. MMP-13
positive chondrocytes of non-operated 11 weeks old Mc1re/e mice (p = 0.0079) and Mc1re/e mice 4 weeks (p = 0.035) after OA induction are
increased compared to WT mice. C) Compared to non-operated controls number of ICAM-1 positive articular chondrocytes of Mc1re/e and WT knee
joints are decreased 4 weeks (Mc1re/e: p = 0.0159; WT: p = 0.0381) and 8 weeks (Mc1re/e: p = 0.0159; WT: p = 0.0159) after OA-induction as well as in
non-operated 6 month old animals (Mc1re/e: p = 0.0317; WT: p = 0.0159). There is no difference between WT and Mc1re/e regarding the number of
ICAM-1 positive chondrocytes in non-operated controls whereas Mc1re/e mice 4 (p = 0.0303) and 8 weeks (p = 0.0079) after OA-induction showed
lower numbers of ICAM-1 positive cells. Mean scores of medial tibia and femur were included in statistical analysis. Data are presented as box plots
reflecting the 25th and 75th percentile as boxes, the median as horizontal line and minimum and maximum values as whiskers. 11 p,0.01 4/8 weeks
post-surgery vs. non-operated, 1 p,0.05 4/8 weeks post-surgery vs. non-operated, ** p,0.01 wild type vs. Mc1re/e, * p,0.05 wild type vs. Mc1re/e.
doi:10.1371/journal.pone.0105858.g004
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subtypes, i.e. MC2 and MC5 were detected in articular cartilage
from newborn mice (data not shown). In contrast to bone,
chondrocytes are the only cell type in cartilage and for them MC1
signaling might be more important than signaling through other
MCR subtypes. Recently, we demonstrated that a-MSH, the high
affinity ligand of MC1, modulated metabolism of articular
chondrocytes by altering gene expression and protein secretion
of several collagens, MMPs and cytokines [15].
In this study we provide evidence that the POMC system can be
chondro-osseo protective and ameliorates OA pathogenesis. In
vivo effects of melanocortin peptides which affect the osteoartic-
ular system are mainly anti-inflammatory and affect bone turnover
and -volume. a-MSH, the high-affinity ligand of MC1 besides
ACTH [12], is reported to reduce collagen-induced arthritis in
mice [28] and to lead to reduced arthritis scores as well as reduced
articular erosions in rat adjuvant arthritis [29]. Interestingly,
a-MSH also reduces tibial perimeter and length. In primary
cultures of osteoblasts and chondrocytes, a-MSH dose dependent-
ly stimulated cell proliferation while in bone marrow cultures,
a-MSH stimulated osteoclastogenesis. Systemic administration of
a-MSH to mice decreased trabecular bone volume in the proximal
tibiae and reduced trabecular number. From this it can be
concluded that a-MSH acts directly on bone, increasing bone
turnover, and, when administered systemically, decreasing bone
volume [30]. These observations are nicely in line with our data
showing increased bone density and bone mass in MC1-signaling
deficient mice after OA-induction. With respect to cartilage matrix
formation, a-MSH and ACTH stimulate matrix production by
increasing collagen II and aggrecan expression in committed
murine and rat chondrocytes [14,15]. This anabolic effect of
melanocortins would help to explain our observation of a articular
cartilage phenotype in native Mc1re/e mice and of more severe
cartilage matrix degradation and loss in OA.
Together with our observation that functional MC1 signaling
delays cartilage degradation and loss during experimental OA
pathogenesis, we also observed alterations in subchondral bone
micro-architecture and osteophyte number in MC1 signaling-
deficient mice after induction of OA. Mutant mice develop clearly
more and larger osteophytes as WT. Osteophyte formation is
besides joint space narrowing, subchondral sclerosis and subchon-
dral cyst formation one of the main radiographic features of OA
and an important criterion for this disease. Osteophytes have a
significant clinical impact and can be a source of pain and loss of
function [31]. In addition to increased osteophyte formation, lack
of MC1 signaling leads to increased subchondral bone mass and
bone density after OA-induction. In early OA, a marked thinning,
Figure 5. Comparison of bone architecture between Mc1re/e and WT mice at the day of DMM surgery (day 0) using mCT. A–F) mCT 3D
analysis of bone parameters was performed within a defined VOI including the tibia epiphysis of both knees respectively. A) Frontal view on 3D
model of the proximal tibia of the right leg showing the VOI marked in purple (L: lateral, M: medial). B) mCT analysis of mean grayscale within the VOI
as an indicator for bone density indicated no difference between WT and Mc1re/e mice. C) 3D calculation of BV/TV within the VOI as an indicator of
bone mass also revealed no difference between both groups. In Trabecular number (Tb.N, D) and trabecular thickness (Tb.Th, E) no difference was
observed whereas trabecular separation (Tb.Sp, F) was increased in Mc1re/e compared to controls (p = 0.028). Values of left and right knees were
combined. Data are presented as boxplots reflecting the 25th and 75th percentile as boxes, the median as horizontal line and minimum and
maximum values as whiskers, stars indicating extreme outliers. * p,0.05 wild type vs. Mc1re/e.
doi:10.1371/journal.pone.0105858.g005
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increase in porosity [23] and hypomineralization of subchondral
bone is observed due to an abnormal high turnover [32] while in
late OA-stages subchondral bone thickening occurs followed by
sclerosis [33]. In line with a significant increase in trabecular
thickness and decrease of trabecular separation, our observations
indicate a more severe and clearly faster progression of subchon-
dral OA-related sclerosis in Mc1re/e mice. Notably, we observed
similar effects, however less pronounced in sham-operated knees at
Figure 6. Radiographic evaluation of osteophytes at 4 and 8 weeks past OA induction. A–C) Knees were oriented as described in material
and methods section and were analyzed for osteophytes (white arrow) in transaxial (A), sagittal (B) and coronal (C) plane. F: femur, T: tibia, Fib: fibula,
L: lateral and M: medial. D) At 4 and 8 weeks the number and size of osteophytes was calculated for the right and the left knee of each animal,
respectively. 4 of 5 Mc1re/e mice developed osteophytes whereas only 2 from 7 WT mice developed one osteophyte after OA-induction.
doi:10.1371/journal.pone.0105858.g006
Figure 7. Alteration of bone density and bone volume at 4 and 8 weeks past OA induction. A–B) Reconstructed coronal image of Mc1re/e
knee joints at the day of OA-surgery (day 0) (A) and 8 weeks after OA-surgery (B). White arrow marks an area of increased mineral deposition (L:
lateral, M: medial). C) mCT analysis of mean grayscale within the VOI of the right knees as an indicator for bone density revealed an increase in bone
densitiy 4 (p = 0.043) and 8 weeks (p = 0.043) after OA-indution in Mc1re/e mice and 8 weeks (p = 0.018) after OA-induction in WT animals. Mc1re/e
mice showed a higher bone density 4 (p = 0.007) and 8 weeks (p = 0.042) after OA-induction compared to WT mice. D) In Mc1re/e mice but not in WT
animals, BV/TV within the VOI of the right knee as an indicator of bone mass was increased at both time points after OA-induction compared to day 0
(p = 0.043). There was a higher bone mass in the epiphysis of Mc1re/e mice 4 (p = 0.007) and 8 weeks (p = 0.004) after OA-induction compared to WT
animals. Data were normalized to the values at day 0 (day of surgery, (set as 1, grey dotted line). Data are presented as boxplots reflecting the 25th
and 75th percentile as boxes, the median as horizontal line and minimum and maximum values as whiskers with dots indicating outliers and stars
indicating extreme outliers. 1 p,0.05 4/8 weeks post-surgery vs. day 0, * p,0.05 and ** p,0.01 wild type vs. mutant.
doi:10.1371/journal.pone.0105858.g007
MC1-Signaling and OA
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e105858
4 and 8 weeks after DMM with increased severity in Mc1re/e
mice. We were unable to detect OA related cartilage matrix
alterations in sham-knees in both groups during that time points
indicating that during early OA alterations in subchondral bone
morphology precede OA related phenotypical changes in cartilage
matrix.
We did not detect obvious differences in MC1 immunostaining
between WT and Mc1re/e mice or during OA progression
indicating that MC1 synthesis per se is not affected by the disease.
Contrary to human OA-cartilage [15], mostly chondrocytes of the
upper and partly the middle layer were MC1 positive while
chondrocytes close to the tide mark remained unstained. These
differences in MC1 distribution might be due to the profound
thinner articular cartilage in mice which consists of only a few cell
layers. Notably, in line with Zhong et al., we also found that
chondrocytes mainly in the proliferative zone of the growth plate
stained positive for the MC1 whereas chondrocytes of the
hypertrophic zone lack not only MC1 expression but mRNA for
all other MCR subtypes [17]. Our unpublished observations
indicated an induction of ICAM-1 gene and protein expression in
human articular OA-chondrocytes in vitro when stimulated with
a-MSH which prompted us to analyze ICAM-1 protein expression
in mouse joints with immunohistochemistry. Notably, we found
strong ICAM-1 immunoreactivity in articular chondrocytes of
non-operated 11 week old Mc1re/e and WT mice which was
decreased in 6 month old animals. Moreover, during pathogenesis
of OA, in cartilage of Mc1re/e mice even less ICAM-1 positive
chondrocytes were detected compared to WT. ICAM-1 is
constitutively expressed on articular chondrocytes [34] and is a
cell surface receptor for hyaluronan (HA) [35,36]. Hyaluronan
and collagen II are two major components of cartilage ECM
which, among other roles, serve as structural components for cell
adhesion. One can speculate that imbalance of these ECM
molecules feeds back on the expression of associated adhesion
molecules like ICAM-1. Loss of ICAM-1 expression after OA-
induction could add to the aggravated degradation of cartilage in
Mc1re/e mice when challenged with DMM. The study of Yasuda
et al. indicate that the interaction of ICAM-1 and HA suppresses
cartilage destruction induced via collagen II peptides and MMP-
13 production [37] suggesting that increased loss of ICAM-1 in
Figure 8. Alteration of bone architecture after OA induction. mCT 3D-analysis of trabecular parameters in the right knee joint (DMM, A–C) and
the left knee joint (Sham, D–F) depicted as trabecular number (Tb.N, A,D), trabecular thickness (Tb.Th, B,E) and trabecular separation (Tb.Sp, C,F). A)
Tb.N declined in WT (p = 0.018) and Mc1re/e (p = 0.043) at both time points after OA-induction compared to day 0 with no differences observed
between both groups. B) Compared to day 0 animals Tb.Th was increased in Mc1re/e mice at both time points (p = 0.043) after OA-induction whereas
WT mice showed an increase only 8 weeks after operation (p = 0.018). Mc1re/e mice had thicker trabeculae at both time points compared to WT
animals (p = 0.004) C) Th.Sp was decreased in Mc1re/e animals reaching significance 8 weeks after OA-induction compared to day 0 mice (p = 0.043).
At both time points, Mc1re/e animals developed less Th.Sp compared to WT group (p = 0.019). Mild alterations in trabecular structure also occurred in
sham operated contra-lateral knees in both groups but to a significantly lesser extend compared to destabilized knees. Data were normalized to the
values at day 0 (day of surgery, set as 1, grey dotted line). Data are presented as box plots reflecting the 25th and 75th percentile as boxes, the
median as horizontal line and minimum and maximum values as whiskers with dots indicating outliers and stars indicating extreme outliers. White
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this context might facilitate OA pathology. Moreover, Lisignoli et
al., demonstrated an anti-apoptotic effect of HA bound to its
receptors CD44 and ICAM-1 [38] not only after OA induction
but already in unchallenged mice.
Conclusions
Inflammatory-like processes originated from OA increase bone
and cartilage turnover and eventually lead to degradation of these
tissues. The osteoarticular system presumably responds to this with
an evolutionary conserved stress response in analogy to the
classical HPA axis, that is increased synthesis of POMC-derived
peptides. The release of such POMC peptides will subsequently
not only modulate the activity of immune cells but also of resident
cells as osteoclasts, osteoblasts, chondrocytes, synoviocytes and
their progenitor cells which carry the appropriate MC-receptors.
Inactivation of the MC1, which is present on chondrocytes and
cells of epiphyseal bone will thus consequently have an effect on
physiology and pathophysiology of diathrodial joint tissues. Our
study demonstrates that signal-deficient Mc1re/e mice have a
cartilage phenotype prior to OA induction which increases in
severity during OA-pathogenesis already in an early stage. In
addition, we suggest that absence of MC1-signaling accelerates
age-related structural cartilage ECM alterations as demonstrated
by loss of collagen II and increased number of MMP-13 positive
chondrocytes. Notably, our data from sham – operated joints
suggest that OA-pathogenesis related alterations in epiphyseal
bone architecture precede alterations in articular cartilage which is
more pronounced in Mc1re/e joints. Understanding the under-
lying molecular mechanisms of the functional role of the POMC
system in joints will eventually help to tailor efficient future
therapies against degenerative joint diseases as OA.
Supporting Information
Figure S1 Isotype control staining for MC1, collagen II,
MMP-13, DIPEN and ICAM-1 immunohistochemistry.
Frontal sections of right knee joints from WT and Mc1re/e mice
of non-operated 11 weeks old (Collagen II and DIPEN) and 6
months old (MC1, MMP-13 and ICAM-1) animals were stained
with antibodies against MC1, collagen II, MMP-13, DIPEN and
ICAM-1and appreciate isotype control antibodies. Representative
pictures of medial parts of the knee joints from WT and Mc1re/e
stained with specific antibodies and isotype control antibodies are
shown. Staining with isotype control antibodies revealed no
staining. Black bars = 200 mm.
(TIF)
Figure S2 Localization of MC1, collagen II, MMP-13
and ICAM-1 in articular cartilage and tibial growth plate
of Mc1re/e and WT mice. Frontal sections of right knee joints
from WT and Mc1re/e mice of non-operated 11 weeks old and 6
months old animals and of mice 4 and 8 weeks after OA-induction
were stained with antibodies against MC1, collagen II, MMP-13
and ICAM-1 as described in material and methods. Representa-
tive pictures of a 5206 magnification of medial, tibial articular
cartilage and tibial growth plate of the knee joints from 11 weeks
old (Collagen II, Col II and MMP-13) and 6 months old (MC1
and ICAM-1) mice are shown. Black bars = 200 mm, white
bars = 25 mm.
(TIF)
Figure S3 Localization of aggrecan neoepitope DIPEN
in knee joints of Mc1re/e and wild type mice. Frontal
sections of right knee joints from WT and Mc1re/e mice of non-
operated (non-op) 11 weeks old and 6 months old animals, and of
mice 4 and 8 weeks after osteoarthritis induction (post operation
(p.o.)) were stained with antibodies against DIPEN as described in
material and methods. A) Representative pictures of medial parts
of the knee joints from each time point are shown. B) Number of
DIPEN positive chondrocytes was scored according to Tab. 3.
Compared to 11 weeks old non-op mice number of DIPEN
positive decreased 4 weeks after OA-induction in both groups
(WT: p= 0,0186 and Mc1re/e: p= 0,0647). Mean scores of medial
tibia and femur were included in statistical analysis. Data are
presented as box plots reflecting the 25th and 75th percentile as
boxes, the median as horizontal line and minimum and maximum
values as whiskers. Bars = 200 mm; 1 p,0.05 4/8 weeks post-
surgery vs. non-operated; (1) p,0.0647 4/8 weeks post-surgery vs.
non-operated.
(TIF)
Figure S4 Intra- and inter-observer agreement of
histological scoring systems. Histological scoring systems
for collagen II (A–B), MMP-13 (C-D), ICAM-1 (E–F) and DIPEN
(G–H) staining were evaluated. Therefore 7 independent observer
scored 10 frontal sections of each staining to obtain inter-observer
agreement and 4 observer scored twice within one week to get
intra-observer variability. Summed scores of medial femoral
condyle (MFC) and medial tibial plateau (MTP) were shown for
collagen II (A), MMP-13 (C), ICAM-1 (E) and DIPEN (G) scoring.
To determine intra-observer agreement, cohens kappa coefficient
between scores of measurement 1 and scores of measurement 2 of
each observer (MV, RB, SG and TN) was calculated. For inter-
observer agreement, cohens kappa coefficient between each
observer of measurement 1 was determined. Mean of cohens
kappa coefficients of collagen II (B), MMP-13 (B), ICAM-1 (F) and
DIPEN (H) scorings were shown.
(TIF)
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